Business Description
ValiRx plc is a UK-based drug development company focused on finding new treatments for cancer and related conditions. Its pipeline includes several experimental therapies at various stages of testing, targeting diseases such as prostate cancer, lung cancer, and endometriosis, as well as a cancer cell treatment using peptide nanoparticles. The company also brings its oncology research into the veterinary space and works in partnership with the University of Dundee. Founded in 2000 and headquartered in London, ValiRx continues to advance its science from early laboratory work through to clinical trials.
